CO2021005050A2 - Agente activo para el cuidado del cabello - Google Patents

Agente activo para el cuidado del cabello

Info

Publication number
CO2021005050A2
CO2021005050A2 CONC2021/0005050A CO2021005050A CO2021005050A2 CO 2021005050 A2 CO2021005050 A2 CO 2021005050A2 CO 2021005050 A CO2021005050 A CO 2021005050A CO 2021005050 A2 CO2021005050 A2 CO 2021005050A2
Authority
CO
Colombia
Prior art keywords
hair care
active agent
care agent
active
hair
Prior art date
Application number
CONC2021/0005050A
Other languages
English (en)
Inventor
Amandine Scandolera
Daniel Auriol
Romain Reynaud
Original Assignee
Givaudan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan Sa filed Critical Givaudan Sa
Publication of CO2021005050A2 publication Critical patent/CO2021005050A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/591—Mixtures of compounds not provided for by any of the codes A61K2800/592 - A61K2800/596

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona un agente activo para el cuidado del cabello que comprende glucósido de taxifolina y N-acetil tirosina y una composición para el cuidado del cabello que comprende tal agente activo para el cuidado del cabello. El agente para el cuidado del cabello puede reducir la aparición cabello gris y blanco en un individuo.
CONC2021/0005050A 2018-10-29 2021-04-20 Agente activo para el cuidado del cabello CO2021005050A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1817625.5A GB201817625D0 (en) 2018-10-29 2018-10-29 Hair care active agent
PCT/EP2019/079509 WO2020089216A1 (en) 2018-10-29 2019-10-29 Hair care active agent

Publications (1)

Publication Number Publication Date
CO2021005050A2 true CO2021005050A2 (es) 2021-09-20

Family

ID=64560460

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2021/0005050A CO2021005050A2 (es) 2018-10-29 2021-04-20 Agente activo para el cuidado del cabello

Country Status (13)

Country Link
US (1) US20210378934A1 (es)
EP (1) EP3873483A1 (es)
JP (1) JP2022509412A (es)
KR (1) KR20210087955A (es)
CN (1) CN112930185A (es)
AU (1) AU2019373573A1 (es)
BR (1) BR112021006922A2 (es)
CO (1) CO2021005050A2 (es)
GB (1) GB201817625D0 (es)
IL (1) IL282458A (es)
MX (1) MX2021004041A (es)
SG (1) SG11202103529SA (es)
WO (1) WO2020089216A1 (es)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4387090A (en) 1980-12-22 1983-06-07 The Procter & Gamble Company Hair conditioning compositions
JP2519024B2 (ja) * 1982-06-07 1996-07-31 花王株式会社 毛髪化粧料
US20010014442A1 (en) * 2000-02-09 2001-08-16 Morris James G. Essential constituent and method of use for maintaining hair coloration or reversing hair discoloration
CN1427709A (zh) 2000-04-03 2003-07-02 宝洁公司 包含精选的卷曲控制剂的护发组合物
JP2002316929A (ja) * 2001-04-18 2002-10-31 Japan Science & Technology Corp Ｌ−セリン又はグリシンからなる抗アポトーシス剤
JP2010031033A (ja) * 2001-11-30 2010-02-12 Ezaki Glico Co Ltd リウマチの症状改善用飲食品
US20040086471A1 (en) * 2002-10-31 2004-05-06 Lin Connie Baozhen Compositions for darkening the skin and/or hair
EP1867729A1 (en) 2006-06-14 2007-12-19 Libragen Water soluble phenolics derivatives with dermocosmetic and therapeutic applications
DE102009044974A1 (de) * 2009-07-23 2011-01-27 Henkel Ag & Co. Kgaa Verwendung von Dihydroquercetin und mindestens einer Aminosäure zur positiven Beeinflussung des natürlichen Pigmentierungsprozesses
US7897184B1 (en) 2009-08-13 2011-03-01 Access Business Group International Llc Topical composition with skin lightening effect
JP2013103933A (ja) * 2011-11-16 2013-05-30 Kn Commerce Co Ltd 白髪の予防・改善剤
WO2013189965A2 (en) * 2012-06-21 2013-12-27 Unilever Plc Hair colouring composition
EP3041583A1 (en) 2013-09-05 2016-07-13 The Procter & Gamble Company Hair care compositions comprising viscoelastic particle
FR3032351B1 (fr) * 2015-02-05 2018-03-23 Gelyma Utilisation d'au moins un extrait de macralgue pour augmenter la synthese de melanine dans les melanocytes
US10561593B2 (en) * 2015-12-28 2020-02-18 Johnson & Johnson Consumer Inc. Hair growth composition and method
CA2973679A1 (en) * 2016-07-15 2018-01-15 Kay Jay, Llc Composition and method for altering hair pigmentation

Also Published As

Publication number Publication date
BR112021006922A2 (pt) 2021-07-20
MX2021004041A (es) 2021-06-04
SG11202103529SA (en) 2021-05-28
US20210378934A1 (en) 2021-12-09
JP2022509412A (ja) 2022-01-20
EP3873483A1 (en) 2021-09-08
AU2019373573A1 (en) 2021-05-27
CN112930185A (zh) 2021-06-08
WO2020089216A1 (en) 2020-05-07
IL282458A (en) 2021-06-30
GB201817625D0 (en) 2018-12-12
KR20210087955A (ko) 2021-07-13

Similar Documents

Publication Publication Date Title
PH12019501575A1 (en) ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFá1 INHIBITORS AND USE THEREOF
CL2023001949A1 (es) Anticuerpos que se dirigen al gp120 de vih y métodos de uso (divisional de solicitud de patente no. 3422-2020)
CL2018000818A1 (es) Composición de oligonucleotidos; métodos para alterar el empalme de un transcripto blanco; y uso de la composición para tratar distrofia muscular de duchenne.
UY37952A (es) Formulaciones de un inhibidor de la quinasa trk macrocíclica
MX370963B (es) Composiciones para el cuidado personal.
CL2016002516A1 (es) “compuestos derivados de espirociclo sustituidos, inhibidores atx; composición farmacéutica que los comprende; y su uso en el tratamiento del cáncer, inflamaciones, dolor neuropático, enfermedades fibróticas, trombosis, entre otros”. pct
WO2018143552A3 (ko) 탈모방지 또는 발모촉진용 주사용 조성물
CL2020000220A1 (es) Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial.
CO2021004141A2 (es) Moduladores de la expresión de pnpla3
BR112022012514A2 (pt) Formas de dosagem sólidas que contêm bactérias e vesículas extracelulares microbianas
BR112018002530A2 (pt) combinações e usos e tratamentos destas
BR112019012107A2 (pt) composições para higiene bucal e métodos para clareamento dental
MX2022005132A (es) Terapia combinada con formulaciones de anticuerpos anti-pvrig y anticuerpos anti-pd-1.
CO2021007006A2 (es) Moduladores de la expresión de irf5
CO2022000270A2 (es) Inhibidores de enzimas
CO2022000266A2 (es) Inhibidores de enzimas
CO2021004681A2 (es) Uso de reboxetina para el tratamiento de narcolepsia
CY1122829T1 (el) Φαρμακευτικη συνθεση για νευροπαθητικο πονο
MX2020007894A (es) Carbonato de calcio tratado mediante reaccion superficial para modificar las propiedades biomecanicas de la piel.
CO2021005050A2 (es) Agente activo para el cuidado del cabello
CO2020008769A2 (es) Moduladores de la expresión dnm2
CL2021003317A1 (es) Medicamento y uso del mismo para tratar infecciones bacterianas que involucran una biopelícula.
MY186286A (en) A pharmaceutical composition for improving or preventing progression of chronic kidney disease
MX2019011951A (es) Secretoma bacteriano para usarse en el tratamiento contra lesiones cutaneas.
CO2022000214A2 (es) Composiciones para el tratamiento de la pérdida del cabello